Writing a Prescription for Safety:

B. Braun CAPS® Announces

New Advancements at ASHP 2008

CAPS® Enhances Safety for Patients, Adds Convenience Through Easy-to-Read Labeling, Standardized O.R. Color-Coding

BETHLEHEM, PA. — December 3, 2008

Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun Medical Inc. (B. Braun) Company, announced today that it will introduce a number of advances to its products and services, including enhanced dose labeling, extended Beyond-Use-Dating and American Society for Testing and Materials (ASTM) color-coding for its new anesthesia syringe product line.

CAPS will feature its latest advances at the 43rd American Society of Health-System Pharmacist Midyear Clinical Meeting and Exhibits (ASHP) being held Dec. 8 – 10 in Orlando (Booth #236).

ASTM standard color-coding on anesthesia syringes and other easy-to-read labeling allow for safer, standardized legibility of compounded sterile preparations (CSPs), a real plus in the fast-paced hospital pharmacy and operating room environments. In addition to making labels easier to read, CAPS is offering extended Beyond-Use-Dating (BUD) which will make ordering outsourced CSPs even more convenient. With the industry’s widest range of service options, including local, same-day delivery, adding value to its service is nothing new.

“At CAPS we’re continuously developing ways to improve the safety of patient medication administration while making the pharmacist’s job easier,” said Todd Jones, Director of Marketing for CAPS. “By enhancing the legibility and size of the drug name, drug class and expiration dates on dose labeling, along with color-coding pre-filled anesthesia syringe labels, the information that pharmacists and caregivers need to read is readily available to them.”

CAPS pharmacies compound and locally deliver TPN, Cardioplegia and other CSPs to more than 1,200 hospitals of all sizes nationwide. Hospitals count on CAPS services to help ensure integrity and sterility of admixtures while reducing regulatory challenges, especially those associated with U.S. Pharmacopoeia Chapter <797> (USP <797>).

About

Central Admixture Pharmacy Services (CAPS®)
Pioneered in 1991, CAPS® has grown into the nation's largest network of outsourcing admixture pharmacies servicing over 1,000 hospitals and home care facilities. CAPS® pharmacies are state-licensed, FDA-registered and operate 365-days a year to admix, dispense and deliver labeled, patient specific and anticipatory IV prescriptions to its growing family of customers.  CAPS® is a B. Braun company.

About

B. Braun

B. Braun is a global leader in infusion therapy and pain management and a pioneer in passive safety devices and PVC-/DEHP-free products. Every day, B. Braun employees worldwide share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance safety for patients, physicians and nurses. 

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun promotes best practices for continuous improvement of healthcare and, guided by its “Sharing Expertise®” philosophy, helps today’s healthcare workers address critical issues including environmental responsibility, medication errors reduction and infection prevention. For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.

CAPS, A B.Braun Company is a registered trademark of

Central Admixture Pharmacy Services, Inc.  Copyright 2009 

All Rights Reserved